1 cells generated from PB-than CBHSPCs. This subset was found to generate both burst-forming unit (BFU-E) and CFU-E colonies in colony-forming assays. To further understand the differences between CB-and PB-HSPC, cells at eight stages of erythroid differentiation were sorted from each of the two sources and their transcriptional profiles were compared. We document differences at the CD34, BFU-E, poly-and orthochromatic stages. Genes exhibiting the most significant differences in expression between HSPC sources clustered into cell cycle-and autophagy-related pathways. Altogether, our studies provide a qualitative and quantitative comparative analysis of human erythropoiesis, highlighting the impact of the developmental origin of HSPCs on erythroid differentiation.
morphologically recognizable erythroid precursor in the bone marrow. 3 Four to five divisions, occurring over the course of four to five days, lead to the orthochromatic stage, followed by enucleation and subsequent formation of the nascent reticulocyte. Reticulocyte maturation is the final stage of erythropoiesis and is characterized by extensive membrane remodeling and the loss of all internal organelles. 4, 5 Studies of erythropoiesis have historically relied, in large part, on mouse models. However, these models have failed to recapitulate various physiologic and pathological aspects of human erythroid differentiation. Indeed, recent studies from our groups and others have highlighted divergent epigenetic, transcriptional, and proteomic landscapes between murine and human erythropoiesis. [6] [7] [8] [9] [10] [11] [12] [13] To better study human erythropoiesis, in vitro culture systems have been developed. Since the original method reported by Fibach, 14 these culture systems have been continually adapted and modified [15] [16] [17] [18] [19] and we are now able to use CD34 1 cells to recapitulate all stages of erythropoiesis, from the HSPC through the reticulocyte stage. These culture systems have promoted the study of normal and disordered erythropoiesis, providing important insights into the mechanisms regulating human erythroid differentiation. However, the majority of these studies used a single source of CD34 1 progenitor cells with the broad assumption that differentiation data obtained from fetal liver (FL), cord blood (CB), bone marrow (BM), and peripheral blood (PB) are roughly equivalent. 6, 8, [20] [21] [22] [23] [24] In addition, comparisons from previous studies were complicated by the inability to isolate pure populations of cells at distinct erythroid stages, a bottleneck that has recently been alleviated by the immunophenotypic characterization of each distinct stage of erythropoiesis. 18, 21 Here, we undertook a comparative analysis of the erythroid differentiation potential of human CB and PB CD34 1 cells, from the BFU-E to the orthochromatic erythroblast. We found that CB-derived CD34
1 cells differentiate at a slower rate than their adult counterparts but exhibit an increased reticulocyte differentiation potential. Furthermore, our studies reveal the existence and maintenance of a population of progenitors that is specific to PB, giving rise to both BFU-E and CFU-E.
To better understand the functional differences between CB-and PBHSPCs, we isolated individual stages of erythropoiesis and performed global gene expression profiles. These data significantly contribute to our understanding of the impact of the developmental origin of HSPCs on erythroid differentiation and provide an important resource for future studies of normal and disordered human erythropoiesis. 
| M A TE RI A L A ND M E TH ODS

| Antibodies
APC-conjugated CD235a (GPA), PE-conjugated-CD34, FITC-conjugated-CD36 and cell viability marker 7-AAD were purchased from BD Biosciences, PE-conjugated a4 integrin from Miltenyi Biotec, PECyanine7-conjugated-IL-3R (CD123) from eBioscience, and a mouse mAb against human Band3 was used as previously described. 18 
| Colony assay
Cells were diluted to a density of 200 cells in 1 mL of MethoCult® H4434 classic medium for BFU-E colony assay with SCF, IL-3, GM-CSF and Epo and 1 mL of MethoCult ® H4330 medium for CFU-E colony assay with Epo only (Stem Cell Technologies) and incubated at 378C in a humidified atmosphere with 5% CO 2 . BFU-E and CFU-E colonies were defined according to the criteria described by Dover et al. 25 CFU-E colonies were counted on day 7 and BFU-E colonies were counted on day 15 by investigators blinded to the experimental conditions. performed and low-quality reads removed. Reads were aligned to the hg19 reference genome using HISAT2. 26 Raw read counts were extracted from the aligned reads using the featureCounts program. 27 Differential expression analysis was assessed at each stage by comparing the two original sources of CD34 1 cells using the DESeq2 bioconductor package. 28 Using gene expression data from each stage, the subset of genes differentially expressed as a function of HSPC source was split into 10 clusters using divisive hierarchical clustering. Gene ontology enrichment analysis of the gene sets was then performed on each cluster using the cluster Profiler R package 29 with the gene background of all genes expressed across all stages in both sources.
| Cytospin preparation
| Statistical analysis
Statistical evaluations between different experimental groups were performed using GraphPad Prism 7 (unpaired t-test) and P < .05 was considered to indicate statistical significance. 
| CB-HSPCs exhibit a slower kinetics of EPOinduced differentiation than PB-HSPCs
The finding that CB-HSPCs proliferated to a significantly greater extent than their adult counterpart led us to investigate the differentiation capacities of the two sources of CD34 1 cells. Using our recently published methods of immuno-phenotyping which allow for the characterization of each stage of human erythroid differentiation, from BFU-E to orthochromatic erythroblasts, we first monitored terminal erythroid differentiation using the expression of three surface markers, namely Glycophorin A (GPA), Band3 and a4-integrin. 18 Low, but detectable GPA HSPCs as compared to their adult PB-derived counterpart.
| Increased persistence of CD34 expression in EPO-differentiated PB-HSPCs as compared to CBHSPCs
Since major differences were observed between Day 5 and Day 8 of culture, at a stage corresponding to the transition from CFU-E to proerythroblast, we further investigated the differentiation of erythroid progenitors and precursors based on the initial source of CD34 1 cells.
Proerythroblasts were sorted on the basis of their expression levels of GPA, Band3, and a4-integrin and their proliferation and differentiation toward orthochromatic erythroblasts were monitored. Although it is well documented that proerythroblasts undergo 4 to 5 cell divisions to generate orthochromatic erythroblasts, no comparative studies using highly pure populations of proerythroblasts have been performed.
Interestingly, the growth patterns of proerythroblasts from both CB and adult PB were very similar (Figure 2A ), suggesting that the growth differences observed between CB-and PB-HSPC sources are the result of a program initiated at the earlier progenitor levels.
We therefore elected to focus on erythroid progenitors, and used the surface markers IL-3R, GPA, CD34, and CD36, to monitor differen- 
| Differences in the transcriptomes of CB-derived and PB-derived HSPC
Using our defined surface markers, cells at each stage of erythroid differentiation were sorted to >95% purity and transcriptomes were compared as a function of the CD34 1 cell source. The principle component analysis is shown in Figure 3A and demonstrates that cells at each distinct stage of development formed distinct clusters in the first two principle components (PC1 and PC2). However, all stages from CB and PB completely separated from each other into their own clusters when viewed using the 3rd principle component (PC1 versus PC3, Figure   3B ). From this analysis, we can conclude that the differences between the two sources are smaller than the differences between stages. The principle component analysis also showed that the gene expression pattern significantly differed during the very early development stages (ie, at the CD34 and BFU-E stages) and at the very late differentiation stages (ie, Polychromatophilic and Orthochromatic erythroblasts). This is in agreement with the significant differences in differentially expressed genes between the two sources at each stage ( Figure 3C ).
We then undertook an in depth comparative analysis of the transcriptome of human erythropoiesis. Many of the differentially expressed genes corresponded to well characterized differences between fetal and adult erythropoiesis, and were used as internal controls for our analysis. 30 These included those responsible for hemoglobin synthesis with fetal globin genes (HBG1, HBG2, and HBE1)
significantly upregulated in CB while adult globin genes (HBB, and HBD) were upregulated in PB. Additionally, the gene encoding the Ibranching enzyme, responsible for the conversion of fetal i antigen to adult I blood group antigen GCNT2, [31] [32] [33] as well as the CA1 and CA2
genes, encoding carbonic anhydrases 1 and 2, 34, 35 were upregulated in PB as compared to CB (Supporting Information Figure S1 ).
To gain further insights into the overall observed changes in the biological processes between CB and PB, the differentially expressed genes at all stages were clustered. Divisive hierarchical clustering was used on the gene expression profile across all stages for both sources and the dendrogram partitioned into 10 clusters as shown graphically in Figure 3D . Gene ontology (GO) enrichment analysis of the biological process gene sets was performed on each cluster (Supporting Information Table S1 ). Clusters 2,3,4, and 8 had gene expression patterns showing differences in expression at the CD34 and BFU-E stages between CB and PB. Of note, Cluster 2 genes showed higher expression at the CD34 and BFU-E stages in CB over PB and enriched GO terms (P.adj < 10
26
) corresponding to leukocyte migration and activation, consistent with CB being less committed to the erythroid lineage than PB which is in agreement with our earlier findings (Figure 2 ). Clusters 1,5,7, and 9 exhibited patterns with differences in expression at the late stages, Polychromatophilic and Orthochromatic erythroblasts.
Among those, Clusters 5 and 7 presented genes with increased expression in PB compared to CB, and these genes are associated with autophagy (P.adj < 10
). Cluster 10 genes exhibited a general increase in expression across many stages from BFU-E to Polychromatophilic erythroblasts in CB-derived cultures and was enriched in GO terms related to cell cycle, mitosis and DNA replication (P.adj < 10
).
Within these clusters, we analyzed our transcriptome data on the basis of several genes critical for erythropoiesis or its regulation. The master regulators of erythropoiesis, defined as members of the core erythroid network, 36 did not differ between CB and PB ( Figure 4A ), highlighting the similarities between the core differentiating programs.
Recently, others have suggested that regulators of globin switching differ between CB and PB. In our study however, these did not significantly change ( Figure 4B ), except for MYB, which was described as unchanged in the Merryweather-Clarke study. 23 Consistent with the flow cytometry data, genes involved in lineage commitment were upregulated in CB, at the CD34 and BFU-E stages ( Figure 4C ), supporting our data that CB-HSPCs have increased proliferative potential as compared to adult PB-HSPCs. This upregulation was however transient and expression levels rapidly decreased as erythroid differentiation progresses to the CFU-E stage. We also observed that genes involved in cell cycle regulation were expressed at higher levels in CB than in PB ( Figure 4D ). Finally, we document that genes involved in the autophagy pathway were upregulated in PB, specifically at the late stages ( Figure   4E ), consistent with a role for autophagy in late stages of erythropoiesis. 37, 38 Altogether, these data highlight the specificity in the developmental regulation of erythropoiesis and the differences between neonatal and adult erythropoiesis.
| D ISC USSION
Erythropoiesis has been extensively studied with much research focusing on terminal erythroid differentiation. As such we have a better understanding of the molecular events leading to the formation of the reticulocyte from the pro-erythroblastic stage. 39 However, much less is known regarding the differentiation of human HSPCs to the precursor stages, and the events leading from the BFU-E to CFU-E progenitor stages have remained largely unexplored, mainly due to the difficulty of obtaining highly enriched populations of human erythroid progenitors.
Different models have been used to study erythropoiesis, and all present their own unique advantages as well as challenges. Differences between species have been highlighted, notably with regards to changes in their transcriptomes during erythroid differentiation. 36 In the present study, we present evidence that even within the same species, the transcriptomes of erythroid progenitors differ as a function of the developmental source of HSPCs.
One of the main strengths of our study is that we used only one variable, the origin of the CD34 1 cells. We induced differentiation of CD34 1 cells from either CB or adult PB using the same culture conditions. We report that these cells exhibit distinct kinetics of differentiation and proliferation. CB-HSPCs lead to the generation of a significantly higher number of reticulocytes than adult PB-HSPC (4-fold) but their kinetics of differentiation is slower. Since the kinetics of growth from sorted pro-erythroblasts to orthochromatic erythroblasts are similar (Figure 2A ), one can rule out terminal differentiation as potential mechanism for the differences observed. However, we document that CB-HSPCs retain IL-3R on their surface for a longer period time. In this context, and in accordance with our data, one may suggest that these cells can generate more immunophenotypically-defined CFU-E, which in turn will lead to a higher number of reticulocytes than PB-HSPCs.
In addition to the immunophenotypically defined IL3R
1 that we previously characterized as a population leading to CFU-E in colony-forming assays, we observe the presence of a population specific to PB-HSPC, immunophenotypically defined as
. Using functional assays, we show that this population represents a transitory state during erythroid differentiation, able to give rise to both BFU-E and CFU-E in vitro. BFU-E generated from this population are heterogeneous in size, which, according to the empirical definition of a BFU-E, 40 suggests that they represent both This study is the first to compare the transcriptomes of sorted erythroid populations derived from PB and CB, allowing for a direct comparison of stage-specific gene expression during human erythropoiesis.
One elegant study published in 2016 compared the transcriptome of human erythropoiesis using CD34 1 cells from CB and adult PB and highlighted a similarity between the erythroid gene expression dynamics of adult and neonatal erythropoiesis. 23 In our study, we found similar data regarding the genes encoding the core erythroid program;
however, we also found significant differences. In their study,
Merryweather-Clarke et al. concluded that the transcriptomes of erythroid progenitors and precursors derived from CB-and adult PBHSPCs were not different. The apparent discrepancies may be due to differences in the in vitro culture systems used in the two studies as well as differences in the analyzed subsets. To control for changes between progenitor populations, all our subsets were sorted, fostering high-resolution transcriptomics analyses.
The culture system utilized here together with the data sets for CB-and PB-derived erythroid progenitors will allow for a more robust evaluation of changes in pathological contexts. Our comparative analysis will undoubtedly foster research of multiple diseases where differentiation is being performed on PB-HSPCs but the majority of comparative data have been obtained using CB-HSPCs.
In summary, our data demonstrate that the source of CD34 1 cells is critical for the study of erythropoiesis, in normal and disordered conditions. It also provides a qualitative and quantitative comparative analysis of human erythropoiesis from CB and adult PB. All of the transcriptome data are deposited on Gene Expression Omnibus (GSE107218). These data will provide a framework for studies of disordered human erythropoiesis and will foster the ex vivo evaluation of new therapeutic strategies for patients with bone marrow failure syndromes.
